Abstract

A reduced blood or oxygen supply to the brain leads to neuronal death caused by excessive activation of glutamate receptors. Recent evidence suggests that two distinct phases of glutamate release produce this death. During ischaemia or hypoxia, glutamate is released by reversed operation of glutamate uptake carriers. It activates N-methyl-D-aspartate (NMDA) receptors, increases the intracellular concentration of Ca2+, and triggers a long-lasting potentiation of NMDA-receptor-gated currents. After ischaemia, glutamate released by Ca(2+)-dependent exocytosis activates an excessive influx of Ca2+ largely through potentiated NMDA-receptor-channels, which leads to neuronal death. The therapeutic implications of such a scheme are discussed.

Keywords

Glutamate receptorNeurosciencePsychologyIschemiaCerebral ischaemiaMedicinePsychiatryInternal medicineReceptor

MeSH Terms

AnimalsBrain IschemiaCell DeathGlutamic AcidHumansNerve DegenerationNeuronsReceptorsN-Methyl-D-Aspartate

Affiliated Institutions

Related Publications

Excitotoxic cell death

Abstract Excitotoxicity refers to the ability of glutamate or related excitatory amino acids to mediate the death of central neurons under certain conditions, for example, after...

1992 Journal of Neurobiology 2307 citations

Publication Info

Year
1994
Type
review
Volume
17
Issue
9
Pages
359-365
Citations
624
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

624
OpenAlex
24
Influential
525
CrossRef

Cite This

Marek Szatkowski, David Attwell (1994). Triggering and execution of neuronal death in brain ischaemia: two phases of glutamate release by different mechanisms. Trends in Neurosciences , 17 (9) , 359-365. https://doi.org/10.1016/0166-2236(94)90040-x

Identifiers

DOI
10.1016/0166-2236(94)90040-x
PMID
7529438

Data Quality

Data completeness: 81%